Wells Fargo analyst: Why a new CEO won't save Valeant By: CNBC.com News April 27, 2016 at 15:33 PM EDT Valeant, whose stock has plunged 65 percent over the last year amid probes into its drug pricing, is too mired in debt to recover, an analyst said. Read More >>